ACP Partners With OpenEvidence to Deliver Clinical Content
The American College of Physicians will license its guidance and Annals of Internal Medicine content to the OpenEvidence AI platform used by U.S. doctors.
Updated on Nov. 9, 2026 in Cancer
Live Poll
Would you trust your doctor's AI tools to give accurate medical guidance?
The American College of Physicians and OpenEvidence announced a collaboration to deliver clinical content to physicians. Under the agreement, OpenEvidence will license ACP evidence-based clinical guidance and published content from Annals of Internal Medicine.
Why it matters
The deal places ACP's clinical guidance directly inside an AI tool physicians already use, making evidence-based recommendations available at the point of care. It reflects how medical knowledge is increasingly delivered through digital platforms rather than print or standalone journals.
The American College of Physicians, with 163,000 members, is the largest medical specialty organization in the United States, and internal medicine is the largest specialty on the OpenEvidence platform. Financial terms of the licensing arrangement have not been disclosed.
The players
American College of Physicians
The American College of Physicians is a medical specialty organization representing internal medicine physicians and is the largest of its kind in the United States, publishing guidance and the journal Annals of Internal Medicine.
OpenEvidence
OpenEvidence is an artificial intelligence platform used by doctors in the United States to access medical information.
The details
OpenEvidence, an AI platform used by doctors in the United States, will license ACP evidence-based clinical guidance and published content from Annals of Internal Medicine. ACP content will be integrated into the platform so physicians can access it at the point of care.
Timeline
1991: The term 'evidence-based medicine' first appeared in print in an ACP journal.
November 9, 2026: ACP and OpenEvidence announced the collaboration.
Health Landscape
The agreement extends the OpenEvidence platform by adding licensed guidance from the American College of Physicians to a tool already used by physicians across the United States. It illustrates a shift toward AI-delivered clinical reference material built on established professional-society publications.
Physicians using the OpenEvidence platform will be able to consult ACP clinical guidance and Annals content during patient visits. Patients may see these recommendations reflected in the treatment decisions their doctors make.
The takeaway
Physicians can expect professional-society guidance to appear more often inside the digital tools they use daily. Readers interested in how their care is informed can ask their doctor which clinical references guide their treatment.
Further reading
Explore more on cancer care and research in the Health section.
Source note: This article includes information reported by News-Medical.
Live Poll
Would you trust your doctor's AI tools to give accurate medical guidance?
